Renoprotective Effect of SGLT 2 Inhibitors Across Diabetic and Non-Diabetic Chronic Kidney Disease
Chronic kidney disease (CKD) is a major health problem that affects individuals with and without diabetes and is associated with progressive loss of kidney function and increased cardiovascular risk. Sodium-glucose cotransporter 2 (SGLT2) inhibitors were initially developed as glucose-lowering agents but have demonstra...